Advertisement
Advertisement

NAUT

NAUT logo

Nautilus Biotechnolgy, Inc. Common Stock

0.98
USD
Sponsored
-0.05
-5.15%
Jul 31, 15:56 UTC -4
Closed
exchange

After-Market

1.01

+0.03
+3.28%

Nautilus Biotechnolgy, Inc. Common Stock Profile

About

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

Info & Links

CEO

Sujal Patel

Headquarters

2701 EASTLAKE AVENUE EAST
SEATTLE, WA 98102, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nautilus.bio

Auditor

PricewaterhouseCoopers LLP

Share holders

27

Employees

130

Nautilus Biotechnolgy, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

128.40M

Enterprise Value

115.23M

Enterprise Value/EBITDA(ttm)

-2.01

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-33.64%

Return on Invested Capital(ttm)

-33.65%

Return on Assets(ttm)

-28.33%

Income Statement

Revenue(ttm)

190.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

175.00K

EBITDA(ttm)3

-57.30M

Net Income Available to Common(ttm)

-56.52M

Diluted EPS(ttm)

-0.47

Share Statistics

Beta (5Y Monthly)

1.08

52-Week Change

28.55%

S&P 500 52-Week Change

20.07%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

127.26M

Dividend Yield

0.00%

Float4

74.55M

% Held by Insiders

41.10%

% Held by Institutions

50.71%

Balance Sheet

Total Cash(mrq)

84.03M

Total Cash Per Share(mrq)

0.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.33%

Quick Ratio(mrq)

13.33%

Book Value Per Share(mrq)

1.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.40

Free Cash Flow(ytd)

-51.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement